126
Participants
Start Date
February 28, 2014
Primary Completion Date
September 30, 2017
Study Completion Date
December 31, 2017
IM-SLNB
IM-SLNB is performed according to the pre-operative lymphoscintigraphy
99mTc-SC
Two syringes of 0.25\~0.5 mCi 99mTc-SC in 0.2\~1.0 mL volume were injected intraparenchymally into 2 quadrants of breast, at the 6 and 12 o'clock positions.
Histologic Examination
All IMSLNs were analyzed by histologic examination for future therapy planning.
LSG
lymphoscintigraphy was performed 0.5\~1.0 hour before surgery
Methylthioninium
Four milliliters of methylthioninium was injected intraparenchymally around the primary tumor 10 min before surgery
Shandong Cancer Hospital, Jinan
Shandong Cancer Hospital and Institute
OTHER